Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionGts Securities Llc
Latest Disclosed Ownership46,218 shares
Latest Disclosed Value $ 1,392,086
Gts Securities Llc ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On May 14, 2026 - Gts Securities Llc filed a 13F-HR form disclosing ownership of 46,218 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $1,392,086 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 0 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). The current value of the position is $1,580,193 USD.

Gts Securities Llc has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 46,218 46,218 1,392 0.0492
2026-02-13 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -104,860 -100.00 0 -100.00
2025-11-14 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 104,860 64,116 157.36 2,118 210.56 0.0813
2025-08-08 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 40,744 23,585 137.45 683 159.32 0.0305
2025-05-15 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 17,159 17,159 264 0.0114
2025-02-18 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -379,668 -100.00 0 -100.00
2024-11-13 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 379,668 988 0.26 6,842 11.18 0.0149
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 378,680 -647,180 -63.09 6,154 -57.49 0.0131
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 1,025,860 276,106 36.83 14,475 84.92 0.0266
2024-02-15 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 749,754 16,409 2.24 7,827 4.64 0.0133
2023-11-15 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 733,345 -19,364 -2.57 7,480 31.99 0.0134
2023-08-16 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 752,709 752,709 5,668 0.1791
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-18 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 386,300 -17.69 6,961 -8.72 n/a n/a n/a
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 469,300 -34.34 7,626 -24.38 n/a n/a n/a
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 714,700 194.36 10,084 297.95 n/a n/a n/a
2024-02-15 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 242,800 5.66 2,535 8.15 n/a n/a n/a
2023-11-15 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Call 229,800 2,344 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-02-18 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-13 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 116,900 -13.79 2,107 -4.40 n/a n/a n/a
2024-08-14 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 135,600 -64.73 2,204 -59.39 n/a n/a n/a
2024-05-15 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 384,500 12.03 5,425 51.41 n/a n/a n/a
2024-02-15 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 343,200 45.86 3,583 49.29 n/a n/a n/a
2023-11-15 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 235,300 2,400 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.